Omega Healthcare Investors, Inc. delivered a strong fourth quarter in 2025, with net income increasing to $172 million and Adjusted FFO per diluted share rising to $0.80. The company made substantial new investments totaling $334 million and repaid $1.27 billion in aggregate debt, contributing to reduced leverage. Full year 2025 results also showed significant growth in net income and AFFO.
Net income for Q4 2025 increased to $172 million, or $0.55 per diluted share, from $116 million, or $0.41 per diluted share, in Q4 2024.
Adjusted FFO for Q4 2025 was $250 million, or $0.80 per diluted share, up from $214 million, or $0.74 per diluted share, in Q4 2024.
The company completed approximately $334 million in new investments during Q4 2025, including real estate acquisitions, real estate loans, and investments in unconsolidated entities.
Omega repaid $1.27 billion of aggregate debt in Q4 2025, including $600 million of senior unsecured notes and a $429 million unsecured term loan.
The Company expects its 2026 Adjusted FFO to be between $3.15 and $3.25 per diluted share, based on several assumptions including new investments, operator payments, and asset sales.
Analyze how earnings announcements historically affect stock price performance